Articles

How is a NEMT business valued in a sale?

From SDE to the buyer's adjusted EBITDA, its allowance for the dialysis contract and its multiple, then the seller note and the van loans: the cash at closing is what is left.

A buyer values a NEMT company on the earnings it expects to keep. In the worked case, FY2026 SDE is $259,601; the buyer's letter adds the stretcher van at its run-rate, takes a fifth of the dialysis contract's contribution off because the center may end it on a change of control, and pays 3.25 times $138,320: $449,540, of which $169,873 reaches the seller at closing.

Worked in full in The NEMT Business Owner by Julian R. Sterling.Get the DRM-free PDF, $19.99 →or the paperback

Free: the NEMT Cost per Trip and Break-Even Calculator in Excel, with the price build, the cost and margin of each trip type and the break-even of the book's case.

Start from what one owner takes out: SDE

Seller's discretionary earnings (SDE) are EBITDA plus the owner's salary and its burden: what the company earns for one owner who runs it. In the worked case, a fictional non-emergency medical transportation company that grew from six vehicles to eleven, SDE was $115,772 in FY2025 ($47,608 of EBITDA plus $68,164 of the owner's salary and burden) and $259,601 in FY2026 ($177,773 plus $81,828).

The jump has causes a buyer will want to name. At the start of FY2026 the company signed a contract with a dialysis center, put four new wheelchair vans on the road, hired a billing clerk and moved its drivers from pay by the completed trip to an hourly wage; a used stretcher van followed in week 66. Revenue went from $460,183 to $1,129,115. A buyer reads the second year, and then asks which parts of it would still be there after a sale.

Example 1: the letter of intent, line by line

On 9 November 2026 a regional transportation company from a neighboring county offers to buy the assets. Every term below is the buyer's, and the owner has not answered.

The letter of intent of 9 November 2026 (worked case, fictional)
LineAmount
EBITDA FY2026$177,773
Stretcher van at its run-rate (the buyer's adjustment)+$2,768
Allowance for the dialysis contract: 20% of its contribution of $211,105−$42,221
Adjusted EBITDA$138,320
Price at 3.25 times$449,540
Seller note, 10% of the price, on full standby−$44,954
Wheelchair van loans repaid at closing−$184,078
Stretcher van loan repaid at closing−$35,635
Line of credit closed−$15,000
Cash to the seller at closing$169,873

Two adjustments go in opposite directions. The stretcher van started in week 66, so FY2026 holds only 39 of its weeks: its last quarter, times four, is a run-rate of $25,604 against the $22,836 it actually left in the year, and the buyer adds the difference, $2,768. The dialysis contract works the other way. The center may end it on a change of control, so the buyer takes a fifth of the contract's contribution, $42,221, off the earnings it pays for.

The book goes further: the owner's four months of introductions to the broker, the dialysis center and the facilities, whether the Medicaid enrollment and the broker agreement can follow the company, and the debt that comes off the price. See the book and its seven workbooks.

The trap: the price is not the cash. The seller note of $44,954 is part of the price but on full standby, and the van loans, $219,713 together, are paid off out of the price at closing. Receivables and cash stay with the seller under the letter; how an asset sale is taxed is for the outside CPA.

What multiple is that?

The price is 3.25 times adjusted EBITDA, 1.73 times FY2026 SDE and 2.53 times FY2026 EBITDA. Those are ratios of the case, not market multiples, and the book quotes no market multiple for NEMT companies. What moves the price most is not the multiple but the allowance: if the buyer took 40 percent of the dialysis contribution instead of 20, adjusted EBITDA would fall to $96,099, the price to $312,322 and the cash at closing to $46,377. One clause in one contract is worth $137,218 of price.

Example 2: how much of the revenue rests on one payer?

A buyer looks at where revenue comes from, because some of it rests on agreements a sale may not carry over.

Share of revenue by payer (worked case, fictional)
PayerFY2025FY2026
The Medicaid broker (its rates, paid 4 weeks after the trip)83.3%67.3%
The dialysis center (contract rate, paid after 5 weeks)0%20.4%
Revenue of the year$460,183$1,129,115

In FY2025 the broker paid five dollars of every six. In FY2026 its share fell to 67.3 percent, not because broker work shrank but because the dialysis contract and the facilities added revenue around it. A company less tied to one payer is easier to hand over, and still the broker remains more than half. Whether the Medicaid enrollment and the provider agreement with the broker can follow a buyer, or must be applied for again, is a question for the state Medicaid agency, the broker and counsel; the case does not answer it, and neither should a seller's spreadsheet.

Example 3: what the buyer must bring with an SBA loan

The letter does not say how the buyer would pay. If it used an SBA 7(a) loan, the SBA's procedures as in force in November 2026 (SOP 50 10 8.1) ask for an equity injection of at least 10 percent of the project cost on an initial acquisition, and seller debt counts toward it only on full standby and only up to half of the required injection. Here that is $44,954 on a project of $449,540; the seller note of $44,954 can count for at most $22,477, so at least $22,477 would have to come from elsewhere. The lender decides; the arithmetic shows what the buyer's letter assumes.

What the seller does with this

The owner answers the letter with three figures, not one: the adjusted EBITDA the buyer pays for, the allowance it takes for the dialysis contract, and the cash left at closing once the note and the loans are counted. Each can be rebuilt in a sheet and argued line by line. The book's workbook 7 does exactly that, from EBITDA to the cash at closing.

Sources

  1. SBA, SOP 50 10 8.1, Lender and Development Company Loan Programs
  2. IRS: S corporation compensation and medical insurance issues
  3. 42 CFR 440.170 (eCFR): any other medical care or remedial care, including the NEMT brokerage program

Figures checked on 18 November 2026. The company in the examples is fictional, and its trips, rates, pay, vehicle prices and costs are teaching assumptions, not market norms, not a broker’s rates and not the rule of any state. Not legal, billing, tax or accounting advice.

Questions readers ask

What is a NEMT business worth?

There is no single answer. In the book's worked case a buyer offers 3.25 times adjusted EBITDA, $449,540, which is 1.73 times SDE. Those are case ratios, not market multiples.

Does a Medicaid broker agreement transfer with the sale of a NEMT company?

Not necessarily. Whether the enrollment and the provider agreement follow a buyer, or must be applied for again, depends on the state program and the broker; the buyer and the seller ask both, and counsel reads the agreement.

Why does the cash at closing differ from the price?

Because the seller note ($44,954) is paid later and the van loans ($219,713) and the line ($15,000) are repaid out of the price. In the case $169,873 of the $449,540 reaches the seller at closing.

Is SDE or EBITDA used to value a NEMT company?

SDE suits a company run by one working owner; a buyer that will run it with a manager reads EBITDA. In the case the letter works from EBITDA FY2026, adjusted for the stretcher van and the dialysis contract.

Read the whole book

This article is one calculation from The NEMT Business Owner, a practitioner’s guide to running a non-emergency medical transportation company by the numbers: Medicaid broker contracts and trip rates, ambulatory, wheelchair and stretcher trips, vehicle economics, driver pay, insurance, cash flow, break-even and what the company is worth, with seven workbooks.

Also on this site